… -weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
… full-length parathyroid hormone (1-84) followed by alendronate significantly increased areal
… with parathyroid hormone therapy followed by placebo or monotherapy with alendronate …
… with parathyroid hormone therapy followed by placebo or monotherapy with alendronate …
Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study
…, H Lin, H Tang, L Shen, X Gao, J Hu, A Chao… - … of Osteoporosis, 2022 - Springer
… with osteoporosis was similar to that of alendronate. It provided a new choice for osteoporosis
… , elevated alkaline phosphatase or parathyroid hormone, dizziness, and arthralgia. …
… , elevated alkaline phosphatase or parathyroid hormone, dizziness, and arthralgia. …
Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled …
S Lou, H Lv, P Yin, Z Li, P Tang, Y Wang - Osteoporosis International, 2019 - Springer
… for osteoporosis. MEDLINE, EMBASE, and Cochrane Library were searched from inception
to May 1, … [16] used PTH 1-84 in combination with alendronate for 12 months, reporting no …
to May 1, … [16] used PTH 1-84 in combination with alendronate for 12 months, reporting no …
… followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis …
… with full-length parathyroid hormone, followed by alendronate significantly increased areal
… with parathyroid hormone therapy, followed by placebo or monotherapy with alendronate …
… with parathyroid hormone therapy, followed by placebo or monotherapy with alendronate …
… sequential treatment of abaloparatide followed by alendronate versus teriparatide followed by alendronate in postmenopausal women with osteoporosis in the United …
… parathyroid hormone-related protein analog, abaloparatide (ABL), for daily subcutaneous
injection for treatment of postmenopausal women with osteoporosis at … to 84, and ⩾85 years 37,…
injection for treatment of postmenopausal women with osteoporosis at … to 84, and ⩾85 years 37,…
… and alendronate versus alendronate alone for elevation of bone mineral density and prevention of refracture after percutaneous vertebroplasty in osteoporosis: a …
D Yang, J Tan, Y Long, K Huang, W Han… - Aging Clinical and …, 2023 - Springer
… we recruited 165 female osteoporosis patients after percutaneous … by alendronate group
(TPTD + ALN group) and alendronate alone … parathyroid hormone and alendronate therapy [27]. …
(TPTD + ALN group) and alendronate alone … parathyroid hormone and alendronate therapy [27]. …
The combined effect of Parathyroid hormone (1–34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a …
DB Jepsen, J Ryg, S Hansen, NR Jørgensen… - Osteoporosis …, 2019 - Springer
… parathyroid hormone (PTH) 1–34 fragment teriparatide is an effective anabolic agent for the
treatment of osteoporosis… and 2.6% at the total hip after eighteen months of treatment and to …
treatment of osteoporosis… and 2.6% at the total hip after eighteen months of treatment and to …
Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a …
A Morita, N Kobayashi, H Choe, H Ike, T Tezuka… - Journal of Orthopaedic …, 2020 - Springer
… for the prevention of BMD loss around the implant over 1 year [… and alendronate was not
effective for osteoporosis [13], … combination of parathyroid hormone (PTH) and alendronate was …
effective for osteoporosis [13], … combination of parathyroid hormone (PTH) and alendronate was …
Effect of abaloparatide vs alendronate on fracture risk reduction in postmenopausal women with osteoporosis
BZ Leder, B Mitlak, M Hu, G Hattersley… - The Journal of …, 2020 - academic.oup.com
… analogue of the human parathyroid hormone–related protein … osteoporosis (10).
Abaloparatide-treated participants from ACTIVE were then treated with the antiresorptive …
Abaloparatide-treated participants from ACTIVE were then treated with the antiresorptive …
Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral …
T Mori, CJ Crandall, T Fujii, DA Ganz - Archives of osteoporosis, 2021 - Springer
… is a recombinant parathyroid hormone that … /alendronate, which in this study was defined
as daily subcutaneous teriparatide for 2 years followed by weekly oral alendronate for 8 years, …
as daily subcutaneous teriparatide for 2 years followed by weekly oral alendronate for 8 years, …